ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

October 3, 1997

Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped

February 8, 1974

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012